DianeW.WaraMD

Grant Support

• Northern California Pediatrics AIDS Treatment CenterNational Institute Of Allergy And Infectious Diseases2002–2006
• Pediatric LATE Outcomes Protocol (Aids Clinical Trials Group: 219c)National Center For Research Resources2005
• Pactg P1057: Phase I/II Randomized Trial Of Cold Adapted Influenza VaccineNational Center For Research Resources2005
• Pactg P1045: Morphologic And Metabolic Abnormalities In Children &YouthNational Center For Research Resources2005
• Pactg P1042s: Cognitive, Behavioral And Psychosocial CorrelatesNational Center For Research Resources2005
• Pactg 1020-A, Version 20National Center For Research Resources2005
• Effects Of Haart On The Recovery Of Immune Function In Hiv-Infected ChildrenNational Center For Research Resources2005
• Phase I/II Study Of Alvac HIV Vaccine In ChildrenNational Center For Research Resources2004–2005
• Pactg P1030: Phase I/II Study Of Lopinavir/Ritonavir In HIV-1 Infected InfantsNational Center For Research Resources2004–2005
• Pactg P1026s:Pharmacokinetic Properties Of Antiretroviral Drugs During PregnancyNational Center For Research Resources2004–2005
• Pactg P1025: Perinatal Core Protocol For Data From Hiv-Infected Pregnant WomenNational Center For Research Resources2004–2005
• Pactg P1024: Evaluation Of Pneumococcal Vaccine In Hiv-Infected ChildrenNational Center For Research Resources2004–2005
• Defective T- And B- Cell Signaling In Patients With Inherited ImmunodeficienciesNational Center For Research Resources2004–2005
• Clinical And Molecular Investigation Of Primary ImmunodeficienciesNational Center For Research Resources2004–2005
• Phase I/II Trial Of Subcutaneous IL-2 With Antiretroviral Therapy In HIVNational Center For Research Resources2004
• Pediatric LATE Outcomes Protocol (Actg 219c)National Center For Research Resources2004
• Pactg P1021: Emtricitabine With Efavirenz And Didanosine In A Once Daily RegimenNational Center For Research Resources2004
• Pactg 1020-A, Version 2.0National Center For Research Resources2004
• Immunological And Neurodevelopmental Consequences Of Chromosome 22q11.2 DeletionNational Center For Research Resources2004
• Quantifying HIV 1 RNA In CSF &Blood Of HIV Infected ChildrenNational Center For Research Resources2000–2002
• ACTG 395: Indinavir W/ Stavudine &Lamivudine For Pediatric HIV 1 InfNational Center For Research Resources2000–2002
• ACTG 377: Pram 2 Comparing 4 Antiretroviral RegimensNational Center For Research Resources2000–2002
• ACTG 366: Antiretroviral Algorithm For Children Of 4 Drug CombinationNational Center For Research Resources2000–2002
• ACTG 351: CD4 Igg2 In HIV Infected ChildrenNational Center For Research Resources2000–2002
• ACTG 316: Nevirapine VS Placebo For Preventing Maternal Fetal TransmissionNational Center For Research Resources1999–2002
• Phase II Rolling Arm Master Protocol Of Novel Antiretroviral Therapy In HIVNational Center For Research Resources1998–2002
• Phase I/II Trial Of Recombinant IL 2 In Symptomatic HIV Infected ChildrenNational Center For Research Resources1998–2002
• Nevirapine VS Placebo To Prevent Maternal-Fetal HIV TransmissionNational Center For Research Resources1998–2002
• Impact Of Diagnostic Disclosure On HIV Infected ChildrenNational Center For Research Resources1998–2002
• Atovaquone In HIV Infected Infants And ChildrenNational Center For Research Resources1998–2002
• Atovaquone And AZT Versus Tmp In HIV Infected ChildrenNational Center For Research Resources1998–2002
• Phase I Evaluation Of Safety/Toxicity Of ZDV And DDI Combination TherapyNational Center For Research Resources1997–2002
• Treating SCID Due To ADA Deficiency With CD34+ Selected Autologous Stem CellsNational Center For Research Resources1995–2002
• Pediatric HIV LATE Outcomes ProtocolNational Center For Research Resources1995–2002
• Clinical Investigation Of The Patient With Primary Immunodeficiency DisorderNational Center For Research Resources1995–2002
• Northern California Pediatric AIDS Treatment CenterNational Institute Of Allergy And Infectious Diseases1988–2001
• Saquinavir Combination Therapy For HIV ChildrenNational Center For Research Resources2000
• Opportunistic Infection Events In HIV Infected ChildrenNational Center For Research Resources2000
• Correlation Of Growth With HIV Viral Load In ChildrenNational Center For Research Resources2000
• Safety And Immunogenicity Of Recombinant HIV 1National Center For Research Resources1998–1999
• Actg250--Safety/Pks Of Nevirapine In HIV1 Infected Pregnant Women/NeonatesNational Center For Research Resources1998–1999
• Single Dose PK And Safety Of Oral Adefovir Dipivoxil In HIV Infected ChildrenNational Center For Research Resources1997–1999
• Phase I/II Study Of Hivig In Slowing Progress Of Disease In HIV Infected ChildNational Center For Research Resources1997–1999
• Hyperimmune Anti HIV Immunoglobulin For Preventing Maternal/Fetal TransmissionNational Center For Research Resources1997–1999
• Combined Zdv-Lamivudine VS DDI VS Zdv-Ddi In HIVNational Center For Research Resources1996–1999
• Three New HIV Vaccines In HIV Infected ChildrenNational Center For Research Resources1995–1999
• Combination Antiretroviral Therapy In Children And Adolescents With Advanced HIVNational Center For Research Resources1995–1999
• AZT VS DDI VS Azt/Ddi Combination In Symptomatic HIV Infected ChildrenNational Center For Research Resources1995–1999
• Atovaquone And AZT Versus Tmp In HIV Infected ChildrenNational Center For Research Resources1997
• Randomized Comparative Trial Of ZDV VS D4T In Children With HIV InfectionNational Center For Research Resources1995–1997
• Phase I Safety And PK Study Of Atovaquone In HIV Infected Infants And ChildrenNational Center For Research Resources1995–1997
• Trial Of DDC In Treatment Of Children With Symptomatic HIV InfectionNational Center For Research Resources1996
• Safety/Pharmacokinetics Of Nevirapine In HIV Infected Pregnant Women/NeonatesNational Center For Research Resources1996
• Pk, Safety, Tolerance And Activity Of Ddc/Zdv In Pediatric Patients With HIVNational Center For Research Resources1996
• Hyperimmune Anti-Hiv Immunoglobulin For Preventing Maternal/Fetal TransmissionNational Center For Research Resources1996
• Atovaquone &Azt Vs. Tmp In HIV Infected ChildrenNational Center For Research Resources1996
• Actg--Pediatric HIV LATE Outcomes ProtocolNational Center For Research Resources1996
• Phase II Trial Of DDC In Treatment Of Children With Symptomatic HIV InfectionNational Center For Research Resources1995
• Phase II Study To Evaluate Pk, Safety, Tolerance And Activity Of DDCNational Center For Research Resources1995
• Phase I Study--Safety And Immungenicity Of HIV-1 Recombinant Envelope AntigenNational Center For Research Resources1995
• HIV-1 Infected Pediatric Slow Or Rapid ProgressorsNational Center For Research Resources1995
• High VS Low Dose Of DDI In Children With Symptomatic HIV InfectionNational Center For Research Resources1995
• BAY Area Perinatal AIDS Cohort StudyEunice Kennedy Shriver National Institute Of Child Health &Human Development1992–1993
• Immunological Sciences Study SectionCenter For Scientific Review1987–1989
• Safety Tolerance And OPEN Efficiency Of Rhcg Immune Serum GlobulinNational Center For Research Resources1985
• Effects Of Thymosin On The Immune Function In ChildrenNational Center For Research Resources1985